INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Total liabilities 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) total liabilities at each fiscal year-end, per SEC filings.
$2.6BFY2025 · since FY2016: $968.3M → $2.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.6B | +2.7% |
| FY2024 | $2.5B | +13.6% |
| FY2023 | $2.2B | +5.2% |
| FY2022 | $2.1B | -0.6% |
| FY2021 | $2.1B | -0.1% |
| FY2020 | $2.1B | +11.3% |
| FY2019 | $1.9B | +8.9% |
| FY2018 | $1.7B | -23.0% |
| FY2017 | $2.2B | +132.3% |
| FY2016 | $968.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IART financial trends
IART RevenueIART Net incomeIART Net marginIART Gross profitIART Gross marginIART Operating incomeIART Operating marginIART Operating cash flowIART Free cash flowIART Capital expendituresIART Return on equityIART Stock buybacksIART Dividends paidIART Total assetsIART Shareholders’ equityIART overview →